Showing 1 - 10 of 1,917
competition after entry. However, less attention has been paid to pricing behavior in anticipation of brand-to-brand competition … manufacturers under tiered-insurance anticipating branded competition. Our model predicts rising prices for incumbent drugs for a …
Persistent link: https://www.econbiz.de/10012925274
We establish four facts concerning competition among U.S. generic drug suppliers, using IQVIA's National Sales … cohorts; (iii) the extent of competition is greatest for the oldest molform cohorts and is smallest for the youngest molform … cohorts. With a median of one competitor, the extent of competition in the youngest molform cohort is very limited; and (iv …
Persistent link: https://www.econbiz.de/10012862864
We examine the issue of new goods and price indexes for the important and tractable case of generic and branded drugs. By treating generics as entirely distinct goods and "linking them in" to indexes with fixed weights, the standard price indexes fail to reflect the substantial welfare gains to...
Persistent link: https://www.econbiz.de/10013243636
I use variation in approval time for generic drugs to shed light on the objectives of the federal agency in charge of granting entry permission for these drugs (FDA). Applications belonging to firms later found to have engaged in fraud or corruption were approved nine months faster on average,...
Persistent link: https://www.econbiz.de/10013324056
Generic pharmaceuticals provide low-cost access to treatment. Despite their chemical equivalence to branded products …
Persistent link: https://www.econbiz.de/10012949948
affects prices to retail pharmacies, plausibly because uncertain quality leads to competition on brand rather than price …
Persistent link: https://www.econbiz.de/10013122879
of competition (e.g. monopoly versus oligopoly). In this paper we model the firm's behavior under different competitive …
Persistent link: https://www.econbiz.de/10013123314
branded pharmaceuticals. We then present a theoretical framework for the pricing of branded pharmaceuticals, without and then …
Persistent link: https://www.econbiz.de/10013139118
generic firms face a negative competition externality which makes their expectations about who else might be planning to enter …
Persistent link: https://www.econbiz.de/10012774927
We study the effects of generic entry on prices and utilization using both event study models that exploit the differential timing of generic entry across drug molecules and cast studies. Our analysis examines drugs treating hypertension, high blood pressure, type 2 diabetes, and depression...
Persistent link: https://www.econbiz.de/10013093453